Suppression of NMDA receptor function using antisense DNA block ocular dominance plasticity while preserving visual...

Area of Science:

• Neuroscience
• Molecular Biology
• Visual System Research

Background:

• Pharmacological blockade of N-methyl-D-aspartate (NMDA) receptors reduces ocular dominance plasticity.
• However, high doses disrupt sensory responses, confounding plasticity studies.
• A method to selectively reduce NMDA receptor function is needed.

Purpose of the Study:

• To investigate the specific role of NMDA receptors in visual plasticity.
• To determine if NMDA receptor blockade's effect on plasticity is independent of sensory response disruption.

Main Methods:

• Used antisense oligodeoxynucleotides (ODNs) to selectively reduce NR1 subunit mRNA and protein levels.
• Performed whole-cell patch-clamp recordings to assess NMDA and AMPA receptor-mediated synaptic transmission.
• Utilized immunocytochemistry and Western blotting to confirm protein reduction.
• Monocular deprivation in ferrets during ODN treatment to assess ocular dominance plasticity.

Main Results:

• Antisense ODN treatment significantly reduced NMDA receptor-mediated transmission without affecting AMPA receptor responses.
• Selective reduction of NR1 protein confirmed by immunocytochemistry and Western blotting.
• Ocular dominance plasticity was decreased in ferrets treated with antisense ODNs.
• Sensory responses, orientation, and direction selectivity of cortical cells remained unaffected.

Conclusions:

• Antisense ODN technology allows for more selective manipulation of cortical function than pharmacological agents.
• This study provides unambiguous evidence for a specific role of NMDA receptors in visual plasticity.
• NMDA receptor function is crucial for ocular dominance plasticity, independent of sensory processing.